Kamal Adawi, CFO of Fate Therapeutics FATE, has filed 0 purchases and 5 sales on the open market. The latest trade was on 01/15.

KA

KA

Kamal Adawi

CFO

Company

Fate Therapeutics FATE

First filing

23/03/03

Trades

11 trades

Buys / sales

0 / 5

12-month net buying

No record

Last trade

01/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ExagenXGN	Open-market sale	24/03/04	24/03/06	12,784 sh2 trades	$1.91avg.	$24,417.44	−5.0%
ExagenXGN	Open-market sale	24/02/06	24/02/08	6,738 sh	$1.95	$13,139.1	−3.6%
ExagenXGN	Open-market sale	23/03/02	23/03/03	3,667 sh	$2.30	$8,434.1	−1.9%
ExagenXGN	Open-market sale	23/02/08	23/02/10	5,821 sh	$2.69	$15,658.49	−6.0%